Article

Botulinum toxin type A approval extends to glabellar lines

Vancouver, British Columbia-The FDA recently approved the injection of botulinum toxin type A (Botox Cosmetic, Allergan, Irvine, CA) to treat moderate to severe glabellar lines in adults under age 65.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) EyeCon 2025: Oluwatosin U. Smith, MD, previews a program of collaborative care and practical learning
Related Content
Using opioids to prevent sneezing and potential ocular tissue damage during sedation and periocular injections
August 24th 2025

Using opioids to prevent sneezing and potential ocular tissue damage during sedation and periocular injections

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
August 24th 2025

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

(Image credit: Ophthalmology Times) From firsts to the future: A pioneer's perspective on ophthalmology
August 24th 2025

From firsts to the future: A pioneer's perspective on ophthalmology

Ehsan Sadri, MD, leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures
August 24th 2025

(EyePod) From idea to impact: Navigating ophthalmic innovation

(Image credit: AdobeStock/ipopba) Robotic precision: Elevating the state of laser cataract surgery
August 24th 2025

Robotic precision: Elevating the state of laser cataract surgery

(Image credit: AdobeStock/zabhie) AI applications in cataract surgery: A surgeon’s perspective
August 24th 2025

AI applications in cataract surgery: A surgeon’s perspective

© 2025 MJH Life Sciences

All rights reserved.